Crohn’s / Ulcerative Colitis Peptide Wafer
Crohn’s disease / Ulcerative colitis
Phase IIActive
Key Facts
About OFD Biopharma
OFD Biopharma, a division of OFD Life Sciences, is a US-based CDMO providing expert lyophilization solutions to stabilize complex pharmaceuticals. The company differentiates itself through its focus on bulk lyophilization and proprietary platforms like LyoLock and LyoPastille, which aim to enhance drug stability, solubility, and bioavailability. It offers end-to-end support from R&D through commercialization, serving clients in oncology, immunology, and other therapeutic areas. As a private service provider, its financial model is based on client contracts and project milestones.
View full company profile